Healthcare Sector

Members of Parliament invested in the Healthcare Sector

157 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£162.71	276.30%	£263,406.57
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£162.71	252.72%	£246,904.41
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£13,578.00	12.92%	£79,046.91
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£13,578.00	229.88%	£230,918.37
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£15,316.00	295.10%	£276,569.07**
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£13,578.00	82.94%	£128,059.82
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£13,578.00	15.32%	£80,725.33
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£13,578.00	409.21%	£356,444.78
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£13,578.00	11.70%	£78,188.55
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£13,578.00	150.66%	£175,458.74
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£13,578.00	13.87%	£79,709.83
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£13,578.00	32.73%	£92,909.09
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£13,578.00	69.62%	£118,733.29
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£13,578.00	362.15%	£323,505.79
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£0.71	-78.52%	£15,036.25
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£52.86	41.37%	£98,962.29
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£56.69	6.10%	£74,271.01**
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£52.86	23.56%	£86,493.69
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£52.86	34.23%	£93,961.40
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£52.86	24.94%	£87,454.50
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£52.86	33.86%	£93,699.67
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£52.86	18.12%	£82,686.03
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£52.86	20.08%	£84,057.25
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£52.86	41.45%	£99,015.26
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£238.33	44.42%	£101,091.32
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£238.33	94.33%	£136,033.11
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£238.33	227.87%	£229,510.24
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£238.33	291.15%	£273,807.65
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£238.33	47.37%	£103,160.40
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£180.79	150.56%	£175,392.27
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£198.61	-20.20%	£55,860.39**
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£316.70	151.15%	£175,804.93**
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£405.55	60.16%	£112,110.02
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£379.86	-22.49%	£54,259.07**
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£405.55	-24.60%	£52,783.40
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£405.55	-21.74%	£54,782.90
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£405.55	-31.77%	£47,759.92
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£356.26	-1.35%	£69,052.20**
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,141.25	69.71%	£118,793.59
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£475.66	13.76%	£79,629.31
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£475.66	3.58%	£72,502.83
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£475.66	-18.50%	£57,049.21
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£475.66	2.73%	£71,907.83
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£475.66	-0.37%	£69,743.41**
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£120.00	-80.41%	£13,712.05
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£120.00	-62.50%	£26,250.00
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£43.96	20.94%	£84,654.75
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£43.96	-56.77%	£30,260.59
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£43.96	-64.19%	£25,068.84
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£43.96	-67.35%	£22,851.63
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£81.40	-51.58%	£33,896.49
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£81.40	-50.01%	£34,995.70
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£153.92	74.16%	£121,909.94
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£153.92	133.04%	£163,128.89
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£153.92	184.82%	£199,373.74
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£219.50	-3.52%	£67,538.46
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£321.70	27.73%	£89,414.34
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£321.70	3.89%	£72,724.05
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£321.70	25.76%	£88,033.62
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£321.70	6.17%	£74,320.13
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£321.70	4.11%	£72,877.03
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£89.65	254.82%	£248,374.64
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£89.65	-17.62%	£57,668.63
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£89.65	172.49%	£190,744.67
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£14.12	-86.05%	£9,766.80
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£26.17	33.90%	£93,729.25
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£26.17	-9.83%	£63,119.41
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£30.67	35.68%	£94,974.39
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£30.67	46.18%	£102,328.88
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£359.74	313.07%	£289,146.87
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£305.64	340.28%	£308,193.63
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£305.64	11.14%	£77,799.28
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£42.80	-10.46%	£62,677.82
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£42.80	-22.11%	£54,522.29
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£14.80	15.53%	£80,874.32
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Dec '25	Lord Sassoon	Medtronic / NYQ:MDT	£100.77	£80.33	-20.28%	£55,801.33
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£100.48	26.49%	£88,539.78
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£77.90	47.93%	£103,551.08**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£35.79	-62.43%	£26,299.60
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£176.51	-35.52%	£45,134.98
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£224.77	39.77%	£97,841.56
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£412.90	48.61%	£104,023.75
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£412.90	17.71%	£82,394.02
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£412.90	-25.10%	£52,426.99
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£3.87	11.21%	£77,844.83**
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29**
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£378.51	1,120.21%	£854,148.96
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£25.50	1.96%	£71,370.88
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,170.00	-18.97%	£56,721.43
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£557.91	1,762.18%	£1,303,528.02
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£1,160.95	58.75%	£111,121.51
Apr '26	Lord Grabiner	Eli Lilly / NYQ:LLY	£955.19	£1,160.95	21.54%	£85,078.88
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,482.00	-26.85%	£51,204.34
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£0.85	-98.04%	£1,372.83
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£1,010.00	81.33%	£126,929.98
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£8.16	482.86%	£407,999.99
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.41	-52.17%	£33,478.26**
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£2.76	43.75%	£100,625.00
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£0.80	-23.27%	£53,711.54
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£48.05	219.27%	£223,488.37
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.03	-98.28%	£1,207.14**
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.30	-97.50%	£1,750.00
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£14.24	34.09%	£93,860.64
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£12.60	12.00%	£78,400.00
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£55.29	83.81%	£128,666.89
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£49.64	-55.67%	£31,030.54
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£334.00	-0.62%	£69,562.63
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£4.56	-63.93%	£25,249.80
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£178.75	-13.86%	£60,301.20
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£178.75	-34.57%	£45,799.78
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.38	-98.56%	£1,009.62
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£68.50	-38.84%	£42,812.50
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£68.50	33.01%	£93,106.80
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£115.07	558.67%	£461,070.43
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£1.06	-96.47%	£2,473.33
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£3.38	-14.43%	£59,898.74

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.